Acutus Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.

Top 25 shareholders own 31.37% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.95%	Deerfield Management Company, L.P. Series C	2,660,808	US$120.1k	0%	no data
8.91%	OrbiMed Advisors LLC	2,648,386	US$119.5k	0%	no data
5.88%	Laurence Lytton	1,746,823	US$78.8k	0%	no data
1.74%	R. Huennekens	518,429	US$23.4k	0%	no data
1.17%	Renaissance Technologies LLC	347,800	US$15.7k	6.36%	no data
0.94%	The Vanguard Group, Inc.	278,220	US$12.6k	-2.75%	no data
0.7%	BlackRock, Inc.	206,681	US$9.3k	0%	no data
0.7%	Geode Capital Management, LLC	206,624	US$9.3k	0%	no data
0.35%	Tom Sohn	105,009	US$4.7k	-11.2%	no data
0.29%	Charlie Piscitello	85,683	US$3.9k	0%	no data
0.26%	Two Sigma Securities, LLC, Asset Management Arm	78,504	US$3.5k	0%	no data
0.25%	Takeo Mukai	72,874	US$3.3k	389%	no data
0.24%	Vincent Burgess	71,650	US$3.2k	0%	no data
0.21%	Kevin Mathews	61,106	US$2.8k	352%	no data
0.17%	State Street Global Advisors, Inc.	51,871	US$2.3k	0%	no data
0.16%	David Roman	47,583	US$2.1k	-57.5%	no data
0.12%	Northern Trust Global Investments	35,038	US$1.6k	0%	no data
0.059%	Morgan Stanley, Investment Banking and Brokerage Investments	17,541	US$791.6	0%	no data
0.044%	Hudson River Trading LLC, Asset Management Arm	13,038	US$588.4	-88.9%	no data
0.042%	David Bonita	12,422	US$560.5	0%	no data
0.042%	Andrew ElBardissi	12,422	US$560.5	0%	no data
0.042%	Shaden Marzouk	12,422	US$560.5	0%	no data
0.04%	Tower Research Capital LLC	11,869	US$535.5	0.89%	no data
0.038%	Niamh Pellegrini	11,181	US$504.6	0%	no data
0.035%	John Sheridan	10,498	US$473.7	0%	no data